Measures to help breast cancer patients avoid early menopause

Australian researchers announced on May 31 that they have discovered a new method that can help breast cancer patients avoid the risk of early menopause.

After conducting research on 218 women from many parts of the world, experts from the Peter MacCallum Cancer Centre in Melbourne discovered that regular monthly injections of goserelin helped to relieve temporary menopause.

Patients who regularly used goserelin during chemotherapy had a 64% lower risk of early menopause. The likelihood of these women still being able to have children after cancer treatment was also nearly double that of those who did not use goserelin.

Experts say this is an important discovery for breast cancer patients, especially young patients. According to statistics, there are about 800 women in Australia who have breast cancer before the age of 40.

In recent years, breast cancer is considered one of the most common cancers in women, especially those in pre-menopause or early menopause.

This is also the disease that causes the highest risk of death among cancers. It is estimated that each year there are about 12 million cases of cancer in the world, of which 1.4 million are breast cancer.

The World Health Organization has warned that if preventive measures, early diagnosis and appropriate lifestyle changes are not promptly strengthened, by 2025, the world will have 19 million women with breast cancer./.

According to Vietnam+